Rejected at 6:04 p.m. Jul, 25, 2025 ] by Ahmed7
Author: bpetro93
Related Note: 1539204159804 1
Rationale for change

All of the asthma treatment cards remain outdated; per GINA 2024, ICS-LABA should be used PRN for steps 1 and 2, low-dose ICS-LABA should be scheduled for step 3, medium-dose ICS-LABA scheduled for step 4, with LAMA and other agents added as needed for step 5.
Source: Other - https://ginasthma.org/wp-content/uploads/2024/06/Whats-New-In-GINA-2024-WEBSITE.pptx

Rejection reason

This card has been updated to reflect the NAEPP guidelines

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
Changed Tags
#AK_Step1_v12::#UWorld::COMLEX::23282
#AK_Step2_v12::#FirstAid::14_Pulm::01_Obstructive_Lung_Disease::02_Asthma #AK_Step2_v12::#NBME::Form09 #AK_Step2_v12::#SketchyPeds::05_Respiratory_&_Pulmonology::02_Lower_Airway_Disease::03_Asthma_in_Children #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step1_v12::#AMBOSS::Ynan7O #AK_Step2_v12::#Resources_by_rotation::FM::casefiles::wheezing&asthma #AK_Step2_v12::Original_decks::Dorian::peds::emma #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Pulmonology::Asthma_management #AK_Step2_v12::#AMBOSS::z60rnS #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#AMBOSS::BxazA5 #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Asthma #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::04_Albuterol_vs_Salmeterol #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step2_v12::#CMS::FM::Form_05 #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma::Management_Redo #AK_Step2_v12::#Subjects::Pulmonology::05_Lungs::Obstructive_Lung_Disease::Asthma #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::02_Chronic_Asthma_Management #AK_Step1_v12::#OME_banner #AK_Step2_v12::#CMS::IM::Form_08 #AK_Step2_v12::#UWorld::Step::23103 #AK_Step2_v12::#UWorld::Step::4617 #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step2_v12::#UWorld::COMLEX::101400 #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #PANCE::EOR::PEDS #AK_Step2_v12::!FLAG_THESE_CARDS::Potential_duplicates #AK_Step2_v12::!Shelf::EM #AK_Step1_v12::#UWorld::Step::169 #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::06_Montelukast_&_Zafirlukast #AK_Step2_v12::!Shelf::#Cards_AnKing_Skipped #PANCE::EOR::Family_med #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::05_Fluticasone_&_Budesonide #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#B&B::20_Pulm::02_Obstructive_and_Restrictive_Diseases::05_Treatment_of_COPD_and_Asthma #AK_Step2_v12::#AMBOSS::BxazA5 #AK_Step2_v12::Original_decks::Dorian::fam::casefiles::wheezing&asthma #AK_Step2_v12::#Resources_by_rotation::Peds::emma #PANCE::EOR::IM #AK_Other::!AK_UpdateTags::Table::Asthma_Treatment